Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005

被引:67
作者
Millar, F. A.
Simmonds, N. J.
Hodson, M. E. [1 ]
机构
[1] Royal Brompton Hosp, London SW3 6NP, England
关键词
Cystic fibrosis; Sputum; Pathogens; Colonisation; TOBRAMYCIN; THERAPY; COLONIZATION; INFECTION; MORTALITY; SURVIVAL; EFFICACY; UPDATE; FLORA;
D O I
10.1016/j.jcf.2009.08.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: The treatment of patients with CF has continued to evolve. We hypothesised that sputum microbiology may have changed as a result of this. Method: Retrospective analysis of sputum microbiology from adult CIF patients (1985 to 2005) using the Royal Brompton Hospital CF database. Results: Colonisation with Pseudomonas aeruginosa or Staphylococcus; aureus between 1985 and 2005 remained stable (77 to 82%, p=0.159; 54 to 47%, p=0.108; respectively). Haemophilus influenzae (48 to 6%; p<0.001), Aspergillus species (18 to 9%; p=0.002) and Burkholderia cepacia complex (9 to 4%; p=0.041) prevalence decreased. Stenotrophomonas maltophilia and MRSA increased (1 to 4%, p=0.02; 1 to 6%, p=0.002, respectively). Conclusion: P. aeruginosa colonisation has remained stable; there has been a decline in B. cepacia complex, H. influenzae and Aspergillus sp., and only a small increase in S. maltophilia and MRSA. Intensive antibiotic strategies have been employed, which, so far, have not resulted in clinically significant emergence of new pathogens. (C) 2009 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:386 / 391
页数:6
相关论文
共 26 条
  • [1] Update in cystic fibrosis 2005
    Accurso, FJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (09) : 944 - 947
  • [2] Beringer P M, 2000, Curr Opin Pulm Med, V6, P545, DOI 10.1097/00063198-200011000-00015
  • [3] Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis
    Burns, JL
    Van Dalfsen, JM
    Shawar, RM
    Otto, KL
    Garber, RL
    Quan, JM
    Montgomery, AB
    Albers, GM
    Ramsey, BW
    Smith, AL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05) : 1190 - 1196
  • [4] Microbiology of sputum from patients at cystic fibrosis centers in the United States
    Burns, JL
    Emerson, J
    Stapp, JR
    Yim, DL
    Krzewinski, J
    Louden, L
    Ramsey, BW
    Clausen, CR
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (01) : 158 - 163
  • [5] Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients
    Cantón, R
    Cobos, N
    de Gracia, J
    Baquero, F
    Honorato, J
    Gartner, S
    Alvarez, A
    Salcedo, A
    Oliver, A
    García-Quetglas, E
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (09) : 690 - 703
  • [6] Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664
  • [7] *CYST FIBR FDN, 2005, PAT REG ANN DAT REP
  • [8] Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257
  • [9] Nutrition and survival in cystic fibrosis
    Elborn, JS
    Bell, SC
    [J]. THORAX, 1996, 51 (10) : 971 - 972
  • [10] Elston C, 2007, BREATHE, V4, P17